Copyright Reports & Markets. All rights reserved.

Global Anti-Senescence Therapy Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Anti-Senescence Therapy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Gene Therapy
      • 1.4.3 Immunotherapy
      • 1.4.4 Others
    • 1.5 Market by Application
      • 1.5.1 Global Anti-Senescence Therapy Market Share by Application (2019-2025)
      • 1.5.2 Cardiovascular Diseases
      • 1.5.3 Neural Degenerative Diseases
      • 1.5.4 Ophthalmology Disorders
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Anti-Senescence Therapy Market Size
    • 2.2 Anti-Senescence Therapy Growth Trends by Regions
      • 2.2.1 Anti-Senescence Therapy Market Size by Regions (2019-2025)
      • 2.2.2 Anti-Senescence Therapy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Anti-Senescence Therapy Market Size by by Players
      • 3.1.1 Global Anti-Senescence Therapy Revenue by by Players (2014-2019)
      • 3.1.2 Global Anti-Senescence Therapy Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Anti-Senescence Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Anti-Senescence Therapy Key Players Head office and Area Served
    • 3.3 Key Players Anti-Senescence Therapy Product/Solution/Service
    • 3.4 Date of Enter into Anti-Senescence Therapy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Anti-Senescence Therapy Market Size by Type (2014-2019)
    • 4.2 Global Anti-Senescence Therapy Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Anti-Senescence Therapy Market Size (2014-2019)
    • 5.2 Anti-Senescence Therapy Key Players in North America
    • 5.3 North America Anti-Senescence Therapy Market Size by Type
    • 5.4 North America Anti-Senescence Therapy Market Size by Application

    6 Europe

    • 6.1 Europe Anti-Senescence Therapy Market Size (2014-2019)
    • 6.2 Anti-Senescence Therapy Key Players in Europe
    • 6.3 Europe Anti-Senescence Therapy Market Size by Type
    • 6.4 Europe Anti-Senescence Therapy Market Size by Application

    7 China

    • 7.1 China Anti-Senescence Therapy Market Size (2014-2019)
    • 7.2 Anti-Senescence Therapy Key Players in China
    • 7.3 China Anti-Senescence Therapy Market Size by Type
    • 7.4 China Anti-Senescence Therapy Market Size by Application

    8 Japan

    • 8.1 Japan Anti-Senescence Therapy Market Size (2014-2019)
    • 8.2 Anti-Senescence Therapy Key Players in Japan
    • 8.3 Japan Anti-Senescence Therapy Market Size by Type
    • 8.4 Japan Anti-Senescence Therapy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Anti-Senescence Therapy Market Size (2014-2019)
    • 9.2 Anti-Senescence Therapy Key Players in Southeast Asia
    • 9.3 Southeast Asia Anti-Senescence Therapy Market Size by Type
    • 9.4 Southeast Asia Anti-Senescence Therapy Market Size by Application

    10 India

    • 10.1 India Anti-Senescence Therapy Market Size (2014-2019)
    • 10.2 Anti-Senescence Therapy Key Players in India
    • 10.3 India Anti-Senescence Therapy Market Size by Type
    • 10.4 India Anti-Senescence Therapy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Anti-Senescence Therapy Market Size (2014-2019)
    • 11.2 Anti-Senescence Therapy Key Players in Central & South America
    • 11.3 Central & South America Anti-Senescence Therapy Market Size by Type
    • 11.4 Central & South America Anti-Senescence Therapy Market Size by Application

    12 International Players Profiles

    • 12.1 Unity Biotechnology
      • 12.1.1 Unity Biotechnology Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Anti-Senescence Therapy Introduction
      • 12.1.4 Unity Biotechnology Revenue in Anti-Senescence Therapy Business (2014-2019))
      • 12.1.5 Unity Biotechnology Recent Development
    • 12.2 Siwa Therapeutics
      • 12.2.1 Siwa Therapeutics Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Anti-Senescence Therapy Introduction
      • 12.2.4 Siwa Therapeutics Revenue in Anti-Senescence Therapy Business (2014-2019)
      • 12.2.5 Siwa Therapeutics Recent Development
    • 12.3 Calico LLC
      • 12.3.1 Calico LLC Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Anti-Senescence Therapy Introduction
      • 12.3.4 Calico LLC Revenue in Anti-Senescence Therapy Business (2014-2019)
      • 12.3.5 Calico LLC Recent Development
    • 12.4 AgeX Therapeutics，Inc
      • 12.4.1 AgeX Therapeutics，Inc Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Anti-Senescence Therapy Introduction
      • 12.4.4 AgeX Therapeutics，Inc Revenue in Anti-Senescence Therapy Business (2014-2019)
      • 12.4.5 AgeX Therapeutics，Inc Recent Development
    • 12.5 Numeric Biotech
      • 12.5.1 Numeric Biotech Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Anti-Senescence Therapy Introduction
      • 12.5.4 Numeric Biotech Revenue in Anti-Senescence Therapy Business (2014-2019)
      • 12.5.5 Numeric Biotech Recent Development
    • 12.6 Human Longevity, Inc. (HLI)
      • 12.6.1 Human Longevity, Inc. (HLI) Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Anti-Senescence Therapy Introduction
      • 12.6.4 Human Longevity, Inc. (HLI) Revenue in Anti-Senescence Therapy Business (2014-2019)
      • 12.6.5 Human Longevity, Inc. (HLI) Recent Development
    • 12.7 Cleara Biotech
      • 12.7.1 Cleara Biotech Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Anti-Senescence Therapy Introduction
      • 12.7.4 Cleara Biotech Revenue in Anti-Senescence Therapy Business (2014-2019)
      • 12.7.5 Cleara Biotech Recent Development
    • 12.8 OisinBiotechnologies
      • 12.8.1 OisinBiotechnologies Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Anti-Senescence Therapy Introduction
      • 12.8.4 OisinBiotechnologies Revenue in Anti-Senescence Therapy Business (2014-2019)
      • 12.8.5 OisinBiotechnologies Recent Development
    • 12.9 Recursion Pharmaceuticals
      • 12.9.1 Recursion Pharmaceuticals Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Anti-Senescence Therapy Introduction
      • 12.9.4 Recursion Pharmaceuticals Revenue in Anti-Senescence Therapy Business (2014-2019)
      • 12.9.5 Recursion Pharmaceuticals Recent Development
    • 12.10 Sierra Sciences
      • 12.10.1 Sierra Sciences Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Anti-Senescence Therapy Introduction
      • 12.10.4 Sierra Sciences Revenue in Anti-Senescence Therapy Business (2014-2019)
      • 12.10.5 Sierra Sciences Recent Development
    • 12.11 Proteostasis Therapeutics
    • 12.12 Senolytic Therapeutics
    • 12.13 Allergan

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Various biomolecules in the system have a large number of active groups, which must interact with each other to produce chemical reactions and slowly cross-link the biomolecules so as to stabilize the chemical activity.With the passage of time, the degree of crosslinking keeps increasing, the consumption of active groups of biological molecules keeps decreasing, and the original molecular structure gradually changes. The accumulation of these changes will gradually lead to the aging phenomenon of biological tissues.Anti-aging treatments include gene therapy, immunotherapy, attention to diseases of the elderly, and so on.
      In 2018, the global Anti-Senescence Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Anti-Senescence Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anti-Senescence Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Unity Biotechnology
      Siwa Therapeutics
      Calico LLC
      AgeX Therapeutics，Inc
      Numeric Biotech
      Human Longevity, Inc. (HLI)
      Cleara Biotech
      OisinBiotechnologies
      Recursion Pharmaceuticals
      Sierra Sciences
      Proteostasis Therapeutics
      Senolytic Therapeutics
      Allergan

      Market segment by Type, the product can be split into
      Gene Therapy
      Immunotherapy
      Others

      Market segment by Application, split into
      Cardiovascular Diseases
      Neural Degenerative Diseases
      Ophthalmology Disorders
      Others

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Anti-Senescence Therapy status, future forecast, growth opportunity, key market and key players.
      To present the Anti-Senescence Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Anti-Senescence Therapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now